The $865 central target reflects the arithmetic mean of approximately 26 recent analyst price targets I reviewed from firms including J.P. Morgan ($940), Mizuho ($950), Canaccord Genuity ($950), Citi ($905), KeyBanc ($905), Barclays ($880), Goldman Sachs ($885), Jefferies ($875), Piper Sandler ($850), RBC Capital ($800), Morgan Stanley ($820), Bank of America ($845), Wells Fargo ($995), and Tigress Financial ($995). The low end of the range sits near $650 (Scotiabank, a Hold) and $685 (BMO Capital), while the high end approaches $995 to $1,000. This distribution is broadly consistent with independent aggregates of roughly $855–$865, though I have not treated any single website's headline consensus as authoritative.
The rating backdrop is decisively constructive: the large majority of analysts rate META a Buy or Strong Buy, with a small minority of Holds and no meaningful Sell ratings. The bullish view rests on durable digital-advertising demand and early monetization of AI features. The cautious minority points to elevated 2026 capital expenditure and thinner near-term earnings visibility, which is why several firms have trimmed targets in recent months while keeping their Buy ratings. Notably, Wedbush has called Meta its top advertising pick for 2026, and Morgan Stanley has flagged Meta as a top pick among hyperscalers, even as both firms hold targets below the $865 mean. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
META last closed near $610, which places the $865 central target about 42% above the current price—a very large move by any standard. The stock traded as high as roughly $779 in its 52-week range and peaked near $793 in August 2025 before a pullback of roughly 30% on concerns about AI spending and monetization. At a trailing P/E (price-to-earnings ratio) of about 21, the valuation is no longer demanding by recent standards, but reaching $865 would likely require both continued double-digit revenue growth and a willingness among investors to pay a higher multiple for that growth.
Meta's core advertising business remains the engine of the bull case. Revenue growth accelerated to about 26% in its most recent quarter, and analysts such as Morgan Stanley project advertising revenue growth of roughly 27% for 2026, driven by AI-enhanced engagement across Reels and improved ad targeting through the Advantage+ suite. Meta also generates substantial free cash flow, pays a modest dividend, and repurchases shares, which supports per-share metrics. If AI spending translates into measurable ad-monetization gains, and if operating-expense growth moderates in 2027, the path toward higher targets becomes more credible.
The principal obstacle is spending. Meta has signaled capital expenditure in the range of $130 billion to $145 billion for 2026 as it builds AI infrastructure, and its Reality Labs segment continues to post large operating losses. Analysts at Oppenheimer, Erste Group, and others have cited this elevated investment as a reason for more cautious stances, arguing it reduces near-term earnings visibility. Additional risks include a broader rotation away from AI-exposed mega-cap stocks, rising interest rates that compress equity valuations, and regulatory scrutiny of Meta's data and distribution practices, which could pressure pricing power. Technical resistance also sits overhead, as the stock trades below both its 50-day and 200-day moving averages.
From a technical standpoint, META is trading below its 200-day simple moving average near $632 and its 50-day average near $675, signaling that the recent trend has been negative. The stock found near-term support around $583–$585 in early November, with the psychological $600 level nearby. On the upside, $631–$632 and $675 represent the first meaningful resistance zones, followed by the 52-week high near $780. A sustained move toward $865 would require first reclaiming and holding above these levels, which implies a broader recovery in both price and investor sentiment. From what I see, cross-checking these levels with Tickeron’s AI Pattern Search Engine adds useful context to the setup.
Analyst price targets are typically set on a roughly 12-month research horizon, although firms do not all apply identical timeframes, and some targets reflect longer-dated valuation work. Investors should monitor Meta's next quarterly earnings and, critically, its guidance for 2027 capital expenditure and operating expenses, since the spending trajectory is the single largest swing factor for the stock. Additional items worth watching include commentary on large-language-model build costs versus licensing, AI-driven ad revenue metrics, Reality Labs losses, any regulatory decisions in the U.S. and Europe, and broader rate-sensitive valuation shifts across mega-cap technology.
The $865 central target—derived from roughly two dozen recent analyst price targets spanning about $650 to $995—represents a roughly 42% advance from META's latest close near $610, a very large move that would likely require both sustained advertising growth and renewed confidence in AI-related spending. The bull case rests on resilient digital-ad demand and early AI monetization, while the bear case centers on heavy capital expenditure, Reality Labs losses, and potential valuation compression. Analyst disagreement is meaningful, with targets concentrated between the mid-$800s and mid-$900s but a cautious tail near $650. The central target is a calculated average, not a guarantee; investors should watch upcoming earnings, 2027 spending guidance, and AI revenue metrics to gauge whether the gap toward $865 can narrow.
In my own research process, Tickeron’s AI Daily Buy/Sell Signals provide a practical way to monitor META and thousands of other names. The system applies artificial intelligence to track technical behavior and market shifts, helping me spot potential changes alongside fundamental analysis and consensus views. It serves as a useful complement when evaluating whether the path to higher targets is gaining traction.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 50-day moving average for META moved above the 200-day moving average on October 06, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where META's RSI Oscillator exited the oversold zone, 23 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 57 cases where META's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
Following a +3.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where META advanced for three days, in 239 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
META may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on META as a result. In 59 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.
The Moving Average Convergence Divergence Histogram (MACD) for META turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 31 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 61%.
META moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for META crossed bearishly below the 50-day moving average on October 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where META declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
The Aroon Indicator for META entered a downward trend on October 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 39 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. META’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 69 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.950) is normal, around the industry mean (0.974). P/E Ratio (22.682) is within average values for comparable stocks, (-39.046). Projected Growth (PEG Ratio) (0.947) is also within normal values, averaging (17.274). Dividend Yield (0.003) settles around the average of (0.979) among similar stocks. P/S Ratio (7.570) is also within normal values, averaging (71.888).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a social networking service and website
Industry InternetSoftwareServices